Deutsche Bank’s Kindred Biosciences, Inc. KIN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-21,600
| Closed | -$198K | – | 4802 |
|
|
2021
Q2 | $198K | Sell |
21,600
-25,215
| -54% | -$147K | ﹤0.01% | 3797 |
|
|
2021
Q1 | $232K | Sell |
46,815
-2,262
| -5% | -$10.9K | ﹤0.01% | 3553 |
|
|
2020
Q4 | $211K | Buy |
49,077
+6,888
| +16% | +$28K | ﹤0.01% | 3443 |
|
|
2020
Q3 | $181K | Buy |
42,189
+1,807
| +4% | +$7.55K | ﹤0.01% | 3272 |
|
|
2020
Q2 | $181K | Buy |
40,382
+6,093
| +18% | +$27.2K | ﹤0.01% | 3189 |
|
|
2020
Q1 | $137K | Buy |
34,289
+20,846
| +155% | +$177K | ﹤0.01% | 3122 |
|
|
2019
Q4 | $113K | Buy |
13,443
+2,642
| +24% | +$20.6K | ﹤0.01% | 3528 |
|
|
2019
Q3 | $73K | Sell |
10,801
-35,580
| -77% | -$261K | ﹤0.01% | 3734 |
|
|
2019
Q2 | $385K | Sell |
46,381
-813,683
| -95% | -$7.02M | ﹤0.01% | 3452 |
|
|
2019
Q1 | $7.88M | Buy |
860,064
+792,364
| +1,170% | +$8.05M | ﹤0.01% | 1533 |
|
|
2018
Q4 | $740K | Sell |
67,700
-4,250
| -6% | -$53.5K | ﹤0.01% | 3078 |
|
|
2018
Q3 | $1M | Sell |
71,950
-74,486
| -51% | -$1.01M | ﹤0.01% | 3328 |
|
|
2018
Q2 | $1.56M | Buy |
146,436
+102,590
| +234% | +$1M | ﹤0.01% | 3128 |
|
|
2018
Q1 | $379K | Sell |
43,846
-93,656
| -68% | -$822K | ﹤0.01% | 3869 |
|
|
2017
Q4 | $1.3M | Sell |
137,502
-72,596
| -35% | -$567K | ﹤0.01% | 3020 |
|
|
2017
Q3 | $1.65M | Sell |
210,098
-22,067
| -10% | -$166K | ﹤0.01% | 2666 |
|
|
2017
Q2 | $2M | Buy |
232,165
+166,751
| +255% | +$1.2M | ﹤0.01% | 2565 |
|
|
2017
Q1 | $461K | Buy |
65,414
+33,298
| +104% | +$209K | ﹤0.01% | 3121 |
|
|
2016
Q4 | $136K | Sell |
32,116
-4,169
| -11% | -$20.2K | ﹤0.01% | 3913 |
|
|
2016
Q3 | $181K | Sell |
36,285
-353
| -1% | -$1.49K | ﹤0.01% | 3697 |
|
|
2016
Q2 | $129K | Buy |
36,638
+33,332
| +1,008% | +$123K | ﹤0.01% | 3983 |
|
|
2016
Q1 | $11K | Sell |
3,306
-15,197
| -82% | -$53.7K | ﹤0.01% | 4804 |
|
|
2015
Q4 | $62K | Buy |
18,503
+13,867
| +299% | +$64.3K | ﹤0.01% | 4298 |
|
|
2015
Q3 | $24K | Sell |
4,636
-46,423
| -91% | -$286K | ﹤0.01% | 4733 |
|
|
2015
Q2 | $347K | Buy |
51,059
+15,230
| +43% | +$108K | ﹤0.01% | 3608 |
|
|
2015
Q1 | $255K | Buy |
35,829
+28,522
| +390% | +$197K | ﹤0.01% | 3668 |
|
|
2014
Q4 | $54K | Buy |
7,307
+7,205
| +7,064% | +$61.1K | ﹤0.01% | 5085 |
|
|
2014
Q3 | $0 | Sell |
102
-2,008
| -95% | -$27.1K | ﹤0.01% | 6177 |
|
|
2014
Q2 | $39K | Buy |
2,110
+1,150
| +120% | +$19.5K | ﹤0.01% | 5044 |
|
|
2014
Q1 | $17K | Buy |
+960
| New | +$18.3K | ﹤0.01% | 4895 |
|
Other funds holding KIN
Deutsche Bank's KIN Position: Q3 2021 in Review
Deutsche Bank sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 21,600 shares — an estimated $198K sold.
Deutsche Bank first reported a position in KIN in Q1 2014 and held it in 30 quarters. The position peaked at $7.88M in Q1 2019. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.
- Deutsche Bank reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
- Deutsche Bank sold 21,600 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $198K.
- Deutsche Bank first reported a position in Kindred Biosciences, Inc. in Q1 2014 and held it in 30 quarters.
- Deutsche Bank's Kindred Biosciences, Inc. position peaked at $7.88M in Q1 2019.
- 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.
Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.